India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday.
from NDTV News Search Records Found 1000 https://ift.tt/XYUh7nv
via IFTTT
-
Take a look at Arjun's post and then Malaika's comment here from NDTV News - Latest http://bit.ly/2I6wZid
-
Nigel Llong lost his cool after being confronted by Virat Kohli over a contentious no-ball call against SunRisers Hyderabad. from NDTV Spo...
-
UK Board result released on the Uttarakhand Board of School Education website. 76.43 per cent students have passed in class 10. from NDTV ...
-
Arvind Kejriwal's rebuttal of Prime Minister Narendra Modi's claim on migrants sparked off a furious Twitter exchange between him an...
-
The Standing Committee of the National Board for Wildlife has called for a review of the guidelines governing Eco-Sensitive Zones around pro...
-
Opening up organ exchange between unrelated individuals may enlarge the donor pool, but policy concerns and risks remain, experts say. Media...
-
Kavitha Jakkal, is one of the two under-50 women, who tried and failed to enter Sabarimala shrine on Friday. She had to stop 500 metres away...
-
The carcasses of a tiger and tigress, who may have died in a territorial fight, were found in the core zone of Tadoba Andhari Tiger Reserve ...
No comments:
Post a Comment